All Articles

With 17 abstracts at AAD 2026, LEO Pharma showcases real-world data to tackle treatment gaps in diverse populations and chronic skin diseases.

As Middle East conflict sends fertilizer and energy prices soaring, Farm Credit Canada expands a key program to help producers navigate the financial storm.

Savaria’s consistent dividend signals robust financial health, tapping into a growing market driven by powerful demographic shifts and the 'aging in place' trend.

Dave Cantin Group's strategic hire of Nate Klebacha signals a new era of data-driven M&A as dealership consolidation continues to accelerate.

NEO Home Loans adopts Better's AI to slash mortgage decision times, signaling a new era of speed. But what are the risks behind the efficiency?

Rutgers Business School is overhauling its MBA in Professional Accounting, cutting costs and adding critical tech skills to prepare a new generation of CPAs.

A major distribution shift sees Southern Glazer’s expand its Pernod Ricard deal into TX, LA, and OK, reshaping the competitive landscape for spirits.

Richtech Robotics hires top-tier auditor CBIZ, citing a strategic shift, but SEC filings reveal a prior warning about a “material weakness” in controls.

Amid a lawsuit, Health Gorilla releases evidence it says proves a partner misrepresented its use of patient data, igniting a debate on trust in health tech.

PetClaw AI launches a new desktop agent that works for you 24/7, promising ultimate productivity. But can its local-first privacy model win in a crowded field?

Winning a top FinTech award, Bags.fm's model has driven $5B in volume, but its innovation comes with the high risks of a volatile new market.

Apple iSports hires innovation guru Ian Wilding to guide its Nasdaq ambitions, a move underscored by a corrective press release signaling growing pains.

A new pilot in LA proves that smart design, not sacrifice, is the key to massive water savings and a better quality of life at home.

Trian Fund Management publicly rejects Victory Capital’s higher offer for Janus Henderson, citing 'significant value destruction' and setting up a showdown.

Old Forester unveils its High Angels' Share Rye, a limited 117 Series release using extreme maturation science to create a hyper-concentrated whiskey.

With a history of billion-dollar deals, Mark Altmeyer takes the helm at ReproNovo, aiming to commercialize its promising fertility and women's health pipeline.

RenovoRx sets a key update call, juggling early RenovoCath device sales with its pivotal Phase III pancreatic cancer trial, a beacon for patients.

China Natural Resources, with a tiny $5M market cap, plans to buy a majority stake in AI startup HooRii for $40M, a high-risk pivot for survival.

A brain aneurysm device successful in Europe has treated its first U.S. patient in a pivotal trial, promising to expand treatment options for thousands.

LA-based Lucky Break PR signals major East Coast ambitions, hiring a seasoned leader to conquer the competitive New York communications market.